BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34428354)

  • 1. ASPM promotes hepatocellular carcinoma progression by activating Wnt/β-catenin signaling through antagonizing autophagy-mediated Dvl2 degradation.
    Zhang H; Yang X; Zhu L; Li Z; Zuo P; Wang P; Feng J; Mi Y; Zhang C; Xu Y; Jin G; Zhang J; Ye H
    FEBS Open Bio; 2021 Oct; 11(10):2784-2799. PubMed ID: 34428354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2E1 plays a suppressive role in hepatocellular carcinoma by regulating Wnt/Dvl2/β-catenin signaling.
    Zhu L; Yang X; Feng J; Mao J; Zhang Q; He M; Mi Y; Mei Y; Jin G; Zhang H
    J Transl Med; 2022 May; 20(1):194. PubMed ID: 35509083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling.
    Pai VC; Hsu CC; Chan TS; Liao WY; Chuu CP; Chen WY; Li CR; Lin CY; Huang SP; Chen LT; Tsai KK
    Oncogene; 2019 Feb; 38(8):1340-1353. PubMed ID: 30266990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TM4SF1, a binding protein of DVL2 in hepatocellular carcinoma, positively regulates beta-catenin/TCF signalling.
    Zhu C; Luo X; Wu J; Liu Y; Liu L; Ma S; Xie R; Wang S; Ji W
    J Cell Mol Med; 2021 Mar; 25(5):2356-2364. PubMed ID: 31876386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin receptor substrate 1/2 (IRS1/2) regulates Wnt/β-catenin signaling through blocking autophagic degradation of dishevelled2.
    Geng Y; Ju Y; Ren F; Qiu Y; Tomita Y; Tomoeda M; Kishida M; Wang Y; Jin L; Su F; Wei C; Jia B; Li Y; Chang Z
    J Biol Chem; 2014 Apr; 289(16):11230-11241. PubMed ID: 24616100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABARAPL1 negatively regulates Wnt/β-catenin signaling by mediating Dvl2 degradation through the autophagy pathway.
    Zhang Y; Wang F; Han L; Wu Y; Li S; Yang X; Wang Y; Ren F; Zhai Y; Wang D; Jia B; Xia Y; Chang Z
    Cell Physiol Biochem; 2011; 27(5):503-12. PubMed ID: 21691068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
    Lo RC; Leung CO; Chan KK; Ho DW; Wong CM; Lee TK; Ng IO
    Cell Death Differ; 2018 Aug; 25(8):1426-1441. PubMed ID: 29445127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dishevelled segment polarity protein 2 promotes gastric cancer progression through Wnt/β-catenin pathway.
    He R; Chen Y; Qian C; Hu Y; Huang X; Tao R
    Tissue Cell; 2023 Jun; 82():102119. PubMed ID: 37257286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
    Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
    Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling.
    Hu W; Wang Z; Zhang S; Lu X; Wu J; Yu K; Ji A; Lu W; Wang Z; Wu J; Jiang C
    Sci Rep; 2019 May; 9(1):7539. PubMed ID: 31101875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis.
    Hsu CC; Liao WY; Chan TS; Chen WY; Lee CT; Shan YS; Huang PJ; Hou YC; Li CR; Tsai KK
    J Pathol; 2019 Dec; 249(4):498-508. PubMed ID: 31465125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of dishevelled 2 is involved in tumor metastasis and is associated with poor prognosis in hepatocellular carcinoma.
    Zhang C; Li C; Chen X; Zhou Y; Yin B; Ni R; Zhang Y; Liu J
    Clin Transl Oncol; 2017 Dec; 19(12):1507-1517. PubMed ID: 28589433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of disheveled-2 resensitizes cisplatin-resistant lung cancer cells through down-regulating Wnt/β-catenin signaling.
    Luo K; Gu X; Liu J; Zeng G; Peng L; Huang H; Jiang M; Yang P; Li M; Yang Y; Wang Y; Peng Q; Zhu L; Zhang K
    Exp Cell Res; 2016 Sep; 347(1):105-113. PubMed ID: 27432651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
    Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
    Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells.
    Fan Q; Yang L; Zhang X; Ma Y; Li Y; Dong L; Zong Z; Hua X; Su D; Li H; Liu J
    J Exp Clin Cancer Res; 2018 Jan; 37(1):9. PubMed ID: 29351758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dishevelled 1-Regulated Superpotent Cancer Stem Cells Mediate Wnt Heterogeneity and Tumor Progression in Hepatocellular Carcinoma.
    Liao WY; Hsu CC; Chan TS; Yen CJ; Chen WY; Pan HW; Tsai KK
    Stem Cell Reports; 2020 Mar; 14(3):462-477. PubMed ID: 32160521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β/catenin and TGF/β-EMT signaling pathways.
    Liu Z; Zhang Y; Xu Z
    J BUON; 2018; 23(1):188-192. PubMed ID: 29552782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor AP-4 promotes tumorigenic capability and activates the Wnt/β-catenin pathway in hepatocellular carcinoma.
    Song J; Xie C; Jiang L; Wu G; Zhu J; Zhang S; Tang M; Song L; Li J
    Theranostics; 2018; 8(13):3571-3583. PubMed ID: 30026867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
    BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation.
    Liu Y; Ye X; Zhang JB; Ouyang H; Shen Z; Wu Y; Wang W; Wu J; Tao S; Yang X; Qiao K; Zhang J; Liu J; Fu Q; Xie Y
    Oncogene; 2015 Oct; 34(44):5524-35. PubMed ID: 25684142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.